Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
P-68<br />
ISBOMC `10 5.7 – 9.7. 2010 <strong>Ruhr</strong>-<strong>Universität</strong> <strong>Bochum</strong><br />
Study <strong>of</strong> Interaction <strong>of</strong> Gold Drugs with Thiols<br />
Using Various Analytical Techniques<br />
Gohar T. Kazimi a* and Mohammad S Iqbal b<br />
a Department <strong>of</strong> Chemistry, University <strong>of</strong> Sargodha, Sargodha 40100, Pakistan. E-mail:<br />
gohartaqi@hotmail.com<br />
b Department <strong>of</strong> Chemistry, GC University, Lahore 54000, Pakistan. E-mail: saeediq50@hotmail.com<br />
Since ancient times, gold has occupied a special place in medicine to cure diseases. Now a days gold<br />
based drugs are being used in the treatment <strong>of</strong> an autoimmune inflammatory disease known as<br />
rheumatoid arthritis (RA). 1 Solganal TM (gold thioglucose), Myochrisine TM (gold sodium thiomalate)<br />
and Ridaura TM (auran<strong>of</strong>in, 2,3,4,6-tetraacetyl-β-1-D-thiogluco-pyranosato-S-(triethyl phosphine)gold(I),<br />
Et3PAuStagl) are used for the treatment <strong>of</strong> this disease but their mode <strong>of</strong> action is still<br />
uncertain. Furthermore, several studies have demonstrated that several gold (I) and gold (III) salts also<br />
exhibit anti-tumour activities. 2-4 The pharmacokinetic and pharmacological properties <strong>of</strong> these drugs<br />
mainly depend upon ligands present on them and various studies have shown that these ligands are<br />
replaced in the body by some endogenous molecules. 1<br />
In this work some <strong>of</strong> the ligand exchange reactions <strong>of</strong> gold drugs with various thiols including<br />
cysteine, glutathione, N-acetylcysteine and O-methylcysteine were studied in both solution and in<br />
solid state. Various analytical techniques like ESI-MS, DESI-MS, pXRD and FT-IR used in this study<br />
confirmed the ligand exchange mechanism. ESI-MS was successfully employed for characterization <strong>of</strong><br />
the ligand-exchange products. When cysteine reacts with auran<strong>of</strong>in in solution, the formation <strong>of</strong><br />
[Et3PAuSCy] – (m/z = 434), [taglSAuCyS] – (m/z = 680) and [Au(Stagl)2] – (m/z = 923) were observed<br />
along with [Au(PEt3)2] + (m/z =433) in the positive-ion spectrum. Similarly with O-methylcysteine the<br />
formation <strong>of</strong> [TaglSSOMeCy] – (m/z = 497), [taglSAuSOMeCyS] – (m/z = 694), [Au(Stagl)2] – (m/z =<br />
923) and [Et3PAuSOMeCy] + (m/z =450) indicated the ligand exchange during reaction. DESI-MS,<br />
pXRD and FT-IR were found to be helpful in characterization the products <strong>of</strong> the reactions performed<br />
in the solid state.<br />
This study provides very useful information in understanding the in vivo biochemistry <strong>of</strong> the gold<br />
drugs used for rheumatoid arthritis.<br />
References<br />
1. C.F. Shaw, III, Chem. Rev. 1999, 99, 2589-2600.<br />
2. E.R.T. Tiekink, P.D. Cookson, B.M. Linahan, L.K. Webster, Metal-Based Drugs 1994, 1,299.<br />
3. L.K.Webster, S. Rainone, E. Horn, E.R.T. Tiekink, Metal-Based Drugs 1996, 3, 63.<br />
4. D. Crump, G. Siasios, E.R.T. Tiekink, Metal-Based Drugs 1999, 6, 361.<br />
126